Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by Red~Oneon Aug 25, 2022 8:25pm

294 Views

Post# 34921376

Off Topic

There are many other names that used to post/pump here on this site and others, one even claimed to be a Doctor, another a professional supervisor, another who boasted that he held half a million shares, n'est-ce pas, one who mortgaged her house for more shares and quite a few others.

I would love to know their opinions about what is going on here now, how things worked out, if they had stop losses set,if they would have done things differently etc.
Paid pumpers need not reply....we are not interested

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario